Las Vegas Sands (LVS) CEO exercises options and sells common shares

Rhea-AI Filing Summary

Las Vegas Sands Corp. Chairman and CEO Robert Goldstein reported option exercises and related stock sales in mid-December 2025. On December 16, 2025, he exercised options to buy 51,350 shares of common stock at an exercise price of $50.33 per share and sold the same number of shares at a weighted average price of $67.58.

On December 17, 2025, he exercised options to buy 1,198,650 shares at $50.33 per share, then sold 1,188,113 shares at a weighted average price of $66.67 and an additional 10,537 shares at a weighted average price of $67.44. Following these transactions, he reports 129,005 shares held indirectly through The Robert and Sheryl Goldstein Trust and also holds 403,800 unvested restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldstein Robert G

(Last) (First) (Middle)

5420 S. DURANGO DRIVE

(Street)

LAS VEGAS NV 89113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LAS VEGAS SANDS CORP [ LVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/16/2025		M		51,350	A	$50.33	51,350	D
Common Stock	12/16/2025		S		51,350	D	$67.58(1)	0	D
Common Stock	12/17/2025		M		1,198,650	A	$50.33	1,198,650	D
Common Stock	12/17/2025		S		1,188,113	D	$66.67(2)	10,537	D
Common Stock	12/17/2025		S		10,537	D	$67.44(3)	0	D
Common Stock								129,005	I	By The Robert and Sheryl Goldstein Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$50.33	12/16/2025		M			51,350	(4)	11/19/2028	Common Stock	51,350	$0	1,198,650	D
Option (Right to Buy)	$50.33	12/17/2025		M			1,198,650	(4)	11/19/2028	Common Stock	1,198,650	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.50 to $67.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.33 to $67.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.33 to $67.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. The options vested as follows: 500,000 on January 1, 2021, 500,000 on January 1, 2022, 500,000 on January 1, 2023, 500,000 on January 1, 2024, and 500,000 on December 31, 2024.

Remarks:

In addition to the options exercised and the underlying shares sold on December 16, 2025 and December 17, 2025, Mr. Goldstein holds 403,800 restricted stock units that are unvested.

	/s/ Judy Tomkins, Attorney-in-Fact	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Las Vegas Sands (LVS) report for December 2025?

Las Vegas Sands reported that Chairman and CEO Robert Goldstein exercised stock options and sold the resulting common shares in transactions dated December 16 and 17, 2025.

How many Las Vegas Sands (LVS) options did Robert Goldstein exercise?

Robert Goldstein exercised options to buy 51,350 shares of Las Vegas Sands common stock on December 16, 2025 and 1,198,650 shares on December 17, 2025, at an exercise price of $50.33 per share in each case.

At what prices did Robert Goldstein sell Las Vegas Sands (LVS) shares?

He reported weighted average sale prices of $67.58 per share on 51,350 shares sold December 16, $66.67 per share on 1,188,113 shares sold December 17, and $67.44 per share on an additional 10,537 shares sold December 17.

How many Las Vegas Sands (LVS) shares does Robert Goldstein report owning after these transactions?

After the reported transactions, Robert Goldstein reports 129,005 shares of Las Vegas Sands common stock held indirectly through The Robert and Sheryl Goldstein Trust.

Does Robert Goldstein still hold equity awards in Las Vegas Sands (LVS)?

Yes. In addition to the exercised options and sold shares, he holds 403,800 restricted stock units that are reported as unvested.

What was Robert Goldstein’s role at Las Vegas Sands (LVS) at the time of these trades?

At the time of the reported transactions, Robert Goldstein was identified as a Director and the company’s Chairman & CEO.